The Hospital of Sant Celoni receives a donation from the UQUIFA company
The Hospital of Sant Celoni receives a donation from the UQUIFA company
News
SONEAS Acquisition
Vivimed announces acquisition of SONEAS by Group´s API business, UQUIFA. SONEAS broadens UQUIFA´s offering in the CDMO sector with New Development capabilities and, an enhanced Project Pipeline
UQUIFA supports innovation
One of the key UQUIFA values is INNOVATION! From its inception 80 years ago, UQUIFA has pioneering novel chemical routes of synthesis, in Barcelona.
Today INNOVATION in Barcelona is championed by the Research Park. Originally created by the University of Barcelona in 1997, the PCB (Parc Científic de Barcelona) was the first in Spain and today is an international leader in promoting INNOVATION.
Uquifa and Kern Pharma partnership the launch Duloxetine
Uquifa jointly with Kern Pharma have developed a generic version of Lilly's Cymbalta (Duloxetine).
Our Lliçà site has passed FDA inspection with no observations
Hard work day by day, and a great team focus on driving the highest standards of quality has allowed Uquifa to obtain good result in the last FDA inspection: zero 483 observations.
An 80 anniversary gift : CPhI in Barcelona
Uquifa is attending to CPhI Worldwide once again. This year is especial as the Barcelona is the venue.
Do not lose the opportunity to meet with one of our sales representatives / CMO delegates or Business Development Managers.
You will be welcome at our booth in CPhI or alternatively we can meet you at your booth for a personal meeting.